Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07113067
Recruiting
Accelerated rTMS vs. Sham for Stroke Apathy
Phase 1/2 · United States · 1 site
Registry update: 8 Jul 2026
NCT06974838
Recruiting
Explore the Therapeutic Effect of Theta Burst Stimulation on Emotion Regulation in Autism With Minimally Verbal Ability or Intellectual Disability
Not applicable · Taiwan · 1 site
Registry update: 16 Sept 2026
NCT06797154
Recruiting
A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Subacute Stroke Survivors
Not applicable · United States · 1 site
Registry update: 28 Nov 2025
2024-516233-12-00
Recruiting
Sotorasib combined with first-line chemotherapy for advanced pancreatic adenocarcinoma
Phase 1 · Spain, France · 26 sites
Registry update: 26 Dec 2025
NCT06974786
Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Phase 2 · United States · 11 sites
Registry update: 4 Jun 2026
NCT07105059
Recruiting
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Phase 1 · United States · 7 sites
Registry update: 13 Oct 2026
NCT06792825
Recruiting
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
Phase 2 · United States · 1 site
Registry update: 12 Aug 2026
NCT06865339
Recruiting
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
Phase 2 · United States · 1 site
Registry update: 13 Apr 2026
NCT07338526
Recruiting
Intensity Modulated PrOton Therapy in Pediatric BRain Tumors (IMPORT)
Not applicable · India · 1 site
Registry update: 30 Jan 2026
NCT06680050
Recruiting
Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
Phase 2 · Switzerland, Italy · 9 sites
Registry update: 18 Dec 2025
NCT07098351
Recruiting
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
Not applicable · China · 1 site
Registry update: 14 Sept 2026
NCT07098338
Recruiting
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Phase 2 · Australia, Canada, China, Spain, France, Italy, Japan, South Korea, Singapore, Thailand, Taiwan, United States · 65 sites
Registry update: 15 Oct 2026
NCT07013565
Recruiting
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
Phase 2 · United States · 1 site
Registry update: 20 May 2026
NCT06854159
Recruiting
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
Phase 2 · United States · 1 site
Registry update: 8 Jul 2026
NCT07111936
Recruiting
Evaluating the Impact of CONNECT in a Multilingual Population
Not applicable · United States · 1 site
Registry update: 13 Aug 2026
NCT07122245
Recruiting
Demographics of Lung Cancer in Females
Not applicable · Egypt · 1 site
Registry update: 18 Aug 2026
NCT06967324
Recruiting
GRACE - Graduated Response for Advanced COPD With Enhanced Support
Not applicable · Denmark · 1 site
Registry update: 10 Dec 2025
NCT06885736
Recruiting
LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
Not applicable · Kuwait · 1 site
Registry update: 21 Apr 2026
NCT06896916
Recruiting
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Phase 1 · Australia, Canada, France, Japan, Netherlands, Norway, United States · 28 sites
Registry update: 12 May 2026
NCT07050433
Recruiting
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Not applicable · United States · 4 sites
Registry update: 27 Aug 2026

Ordered by registry start date. Freshness and sponsorship never change the order.